v3.25.2
Unaudited Interim Consolidated Balance Sheets
¥ in Thousands, $ in Thousands
Jun. 30, 2025
CNY (¥)
Jun. 30, 2025
USD ($)
Dec. 31, 2024
CNY (¥)
Current assets      
Cash and cash equivalents ¥ 159,028 $ 22,199 ¥ 126,531
Accounts receivables, net 337,437 47,104 287,860
Prepayments and other receivables, net 249,513 34,831 248,494
Inventories, net 1,182 166 3,704
Total current assets 747,160 104,300 666,589
Property and equipment 140,308 19,586 147,303
Right-of-use assets 40,943 5,715 43,156
Intangible assets 9,087 1,268 9,986
Deferred tax assets 16,649 2,324 28,147
Long-term investment 98,512 13,752
Other non-current assets 13,182 1,840 13,182
Total non-current assets 318,681 44,485 241,774
Total assets 1,065,841 148,785 908,363
LIABILITIES AND SHAREHOLDERS’ DEFICIT      
Contract liabilities 6,676 932 19,991
Trade and bills payables 69,085 9,644 70,690
Other payables and accruals 232,577 32,466 141,888
Short-term borrowings 90,834 12,680 45,893
Lease liabilities 7,931 1,107 9,401
Tax payable 3,945 551 2,182
Total current liabilities 411,048 57,380 290,045
Lease liabilities-non current 28,233 3,941 27,902
Long-term borrowings 46 6 1,474
Total non-current liabilities 28,279 3,947 29,376
Total liabilities 439,327 61,327 319,421
Commitments and Contingencies
SHAREHOLDERS’ DEFICIT      
Treasury shares (31) (4) (31)
Additional paid-in capital 175,847 24,547 175,847
Statutory surplus reserve 12,946 1,807 9,367
Accumulated losses (587,657) (82,034) (621,794)
Total Youlife Group Inc. shareholders’ deficit (398,746) (55,663) (436,462)
Non-controlling interests 19,212 2,682 19,356
Total shareholders’ deficit (379,534) (52,981) (417,106)
Total liabilities, mezzanine equity and shareholders’ deficit 1,065,841 148,785 908,363
Series C and Series C+ convertible redeemable preferred shares      
Mezzanine equity:      
Series C and Series C+ convertible redeemable preferred shares (US$0.0001 par value: 24,707,091 shares authorized Six Months Ended June 30, 2025 and December 31, 2024; 24,707,091 shares issued and outstanding Six Months Ended June 30, 2025 and December 31, 2024, respectively)1 [1] 1,006,048 140,439 1,006,048
Class A Ordinary Shares      
SHAREHOLDERS’ DEFICIT      
Ordinary shares (US$0.0001 par value; 400,000,000 Class A ordinary shares authorized Six Months Ended June 30, 2025 and December 31, 2024; 34,132,101 shares issued and outstanding Six Months Ended June 30, 2025 and December 31, 2024, respectively; 11,160,808 Class B ordinary shares authorized Six Months Ended June 30, 2025 and December 31, 2024; 11,160,808 shares issued and outstanding Six Months Ended June 30, 2025 and December 31, 2024, respectively)1 [1] ¥ 149 $ 21 ¥ 149
[1] Shares outstanding for all periods reflect the adjustment for Recapitalization.